CENPCP1: A Potential Drug Target and Biomarker for TCF1-Mediated Diseases

Target Name: CENPCP1

NCBI ID: G1061

CENPCP1

Other Name(s): CENPC1P1 | CENPC2 | Centromere protein C 1 pseudogene 1 | CENPC | centromere protein C pseudogene 1

CENPCP1: A Potential Drug Target and Biomarker for TCF1-Mediated Diseases

CENPCP1 (CENPC1P1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the superfamily of cytoplasmic proteins, which are involved in various cellular processes such as signaling, energy metabolism, and transport.

One of the unique features of CENPCP1 is its ability to interact with other proteins, particularly the protein known as TCF1 (T-cell factor 1). TCF1 is a transcription factor that plays a critical role in the development and maintenance of tissues, including the brain. It is known to promote the transcription of genes involved in cell proliferation, differentiation, and survival.

CENPCP1 has been shown to play a role in TCF1-mediated signaling pathways. It has been shown to physically interact with TCF1, and can also inhibit TCF1-mediated signaling pathways. This suggests that CENPCP1 may be a drug target or biomarker for TCF1-mediated diseases.

In addition to its role in TCF1 signaling, CENPCP1 has also been shown to be involved in the regulation of various cellular processes, including cell adhesion, migration, and the association with theNotch signaling pathway.

CENPCP1 has also been shown to be involved in the regulation of inflammation, which is a critical aspect of many diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. It has been shown to play a role in the regulation of immune cell function and the production of pro-inflammatory cytokines.

Given its involvement in TCF1 signaling, CENPCP1 is a promising target for the development of drugs for various diseases. For example, CENPCP1 has been shown to be involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Therefore, compounds that can inhibit CENPCP1 activity may be effective in treating these diseases.

In addition to its potential therapeutic applications, CENPCP1 is also a valuable biomarker for the diagnosis and monitoring of various diseases. Its expression has been shown to be involved in the development of various diseases, including neurodegenerative diseases, cancer, and autoimmune diseases. Therefore, measuring the expression of CENPCP1 may be a useful diagnostic tool for these diseases.

In conclusion, CENPCP1 is a protein that is involved in various cellular processes throughout the body. Its ability to interact with TCF1 and its involvement in TCF1 signaling pathways, as well as its involvement in the regulation of cell adhesion, migration, inflammation, and the association with theNotch signaling pathway, make it a promising target for the development of drugs and biomarkers. Further research is needed to fully understand the role of CENPCP1 in these processes and its potential as a drug target or biomarker.

Protein Name: Centromere Protein C Pseudogene 1

The "CENPCP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CENPCP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets